Patent ID: 7589206

Claim:
A compound of formula (I) wherein: X 1 is NR 12 and X 2 and X 3 together form a —CR 13 ═CR 11 - group or X 3 is NR 12 and X 2 and X 1 together form a —CR 13 ═CR 11 - group; R 1 is selected from hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl and halosubstitutedC 1-6 alkyl; R 2 is hydrogen or (CH 2 ) m R 3 where m is 0 or 1; or R 1 and R 2 together with N to which they are attached form an optionally substituted 4- to 8- membered non-aromatic heterocyclyl ring; R 3 is a 4- to 8- membered non-aromatic heterocyclyl group, a C 3-8 cycloalkyl group, a straight or branched C 1-10 alkyl, a C 2-10 alkenyl, a C 3-8 cycloalkenyl, a C 2-10 alkynyl, a C 3-8 cycloalkynyl or phenyl group, any of which can be unsubstituted or substituted, or R 5 ; R 4 is selected from hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl, halosubstitutedC 1-6 alkyl, COCH 3 and SO 2 Me; R 5 is wherein p is 0, 1 or 2, and X is CH 2 , O, S, or SO 2 ; R 6 is unsubstituted or substituted phenyl, unsubstituted or substituted C 3-6 cycloalkyl or an unsubstituted or substituted 4- to 8- membered non-aromatic heterocyclyl ring; or R 4 and R 6 together with N to which they are attached form an optionally substituted 4- to 8- membered non-aromatic heterocyclyl ring; R 7 is OH, C 1-6 alkoxy, NR 8a R 8b , NHCOR 9 , NHSO 2 R 9 or SOqR 9 ; R 8a is H or C 1-6 alkyl; R 8b is H or C 1-6 alkyl; R 9 is C 1-6 alkyl; R 10 is hydrogen, substituted or unsubstituted (C 1-6 )alkyl or chloro; R 11 is hydrogen or C 1-6 alkyl; R 12 is hydrogen or C 1-6 alkyl; R10 is hydrogen; q is 0, 1 or 2; or a pharmaceutically acceptable salt thereof wherein the compound is not 3-methyl-7-morpholin-4-yl-1H-pyrrolo[2,3-c]pyridine-4-carboxylic acid (tetrahydro-pyran-4-yl)-amide or 3-methyl-7-morpholin-4-yl-1H-pyrrolo[2,3-c]pyridine-4-carboxylic acid (tetrahydro-pyran-4-ylmethyl)-amide.